LGR5 and ovarian carcinoma: In recent years, many studies have shown that LGR5 is highly expressed in multiple malignant tumor types, including colorectal cancer, ovarian cancer, hepatocellular carcinoma, basal cell carcinoma, and esophageal adenocarcinoma.